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Oxidative stress is involved in the pathogenesis of ischemic neuronal injury. A Chinese herbal formula composed of Poria cocos
(Chinesename:Fu Ling),Atractylodes macrocephala(Chinesename:BaiZhu)andAngelicasinensis(Chinesenames:Danggui,Dong
quai, Donggui; Korean name: Danggwi) (FBD), has been proved to be beneﬁcial in the treatment of cerebral ischemia/reperfusion
(I/R).This study was carried out to evaluate the protective eﬀect of FBD against neuronal oxidative stress in vivo and in vitro.
Rat I/R were established by middle cerebral artery occlusion (MCAO) for 1h, followed by 24h reperfusion. MCAO led to
signiﬁcant depletion in superoxide dismutase and glutathione and rise in lipid peroxidation (LPO) and nitric oxide in brain.
The neurological deﬁcit and brain infarction were also signiﬁcantly elevated by MCAO as compared with sham-operated group.
All the brain oxidative stress and damage were signiﬁcantly attenuated by 7 days pretreatment with the aqueous extract of FBD
(250mgkg−1, p.o.). Moreover, cerebrospinal ﬂuid sampled from FBD-pretreated rats protected PC12 cells against oxidative insult
induced by 0.2mM hydrogen peroxide, in a concentration and time-dependent manner (IC50 10.6%, ET50 1.2h). However,
aqueous extract of FBD just slightly scavenged superoxide anion radical generated in xanthine–xanthine oxidase system (IC50
2.4mgml−1) and hydroxyl radical generated in Fenton reaction system (IC50 3.6mgml−1). In conclusion, FBD was a distinct
antioxidant phytotherapy to rescue neuronal oxidative stress, through blocking LPO, restoring endogenous antioxidant system,
but not scavenging free radicals.
1.Introduction
Acute ischemic stroke is a leading cause of death in the
majority of countries [1]. Evidence aﬀords the involve-
ment of oxidative stress in neuronal injury during brain
ischemia/reperfusion (I/R) [2–4]. The lethal process was
accompanied by elevated free radicals, including superoxide
anion (O
•−
2 ), hydroxyl radical (•OH) and hydrogen peroxide
(H2O2), as well as progressive depletion in endogenous
antioxidant system, including antioxidant enzymes, super-
oxide dismutase (SOD), glutathione peroxidase (GSH-Px)
and catalase, or antioxidants, glutathione (GSH), Vitamin
(Vit) C and Vit E (α-tocopherol) [5]. Pathological free
radicals directly damage neuronal proteins, lipids and DNA;
generate toxic lipid peroxides and ultimately contribute to
brain infarction and neurobehavioral symptoms. Although
free radical scavengers, for example, edaravone [6]o re x t r a c t
ofGinkgo biloba (EGb761)[7],havebeendemonstratedtobe
antagonistic to brain I/R, the anti-I/R agents available were
still far from suﬃcient [8].
In traditional Chinese medicine, Poria cocos (Chinese
name: Fu Ling), the dried sclerotia of P. cocos (Schw.) Wolf
(Polyporaceae), is used as a diuretic, sedative and tonic [9].
Triterpene acids and polysaccharides are the principal ingre-
dients of P. cocos that are responsible for diverse bioactiv-
ities, including antitumor, anti-inﬂammatory, nematicidal,
antioxidant, anti-rejection and anti-emetic eﬀects, and act
as inhibitors against DNAtopoisomerases, phospholipase A2
and cholinesterase (see [9–16], Table 1). The dried rhizome
of Atractylodes macrocephala Koidz. (Compositae) (Chinese
name: Bai Zhu)i su s e da sad i g e s t i v ea n dat o n i c ,i nw h i c h
volatile oils, polysaccharides, sesquiterpenes and ﬂavonoids
were identiﬁed with anti-inﬂammatory, hypoglycemic and
gastrointestinal inhibitory eﬀects, and so forth. (see [10–12,2 Evidence-Based Complementary and Alternative Medicine
Table 1: Active ingredients and physio-pharmacologicalfunctions of P. cocos, A. macrocephala and A. sinensis.
Herbs Active ingredients Physio-pharmacologicalfunctions
P. cocos Triterpene acids, Polysaccharides
Antitumor activity and DNA topoisomerasesinhibitory activity,
anti-inﬂammatoryand anti-phospholipase A(2) activity,
nematicidal, antioxidant, anti-cholinesterase, anti-rejection,
anti-emetic and anti-nephritic eﬀects
A. macrocephala Volatile oils,Polysaccharides, Sesquiterpenes,
Flavonoids
Anti-inﬂammatory, antitumor activity, gastrointestinal inhibitory
eﬀect, suppression of allergic diarrhea and uterine contraction,
antioxidant and hypoglycemic eﬀects, diuresis angiogenesis
A. sinensis
Volatile oils,Polysaccharides, Coumarin
derivatives, Organic acids, Vitamins and
minerals
Anticoagulation, antiplatelet activity, hematopoiesis,immune
support, anti-inﬂammatory,antioxidant, antiﬁbrotic and
antispasmodiceﬀects, uterine tonicity
17–20], Table 1). The dried root of Angelica sinensis (Oliv.)
Diels (Umbelliferae) (Chinese names: Danggui, Dong quai,
Donggui; Korean name: Danggwi) is used as a vital blood
tonic and especially to treat gynecological diseases. Due to
its varied constituents, such as volatile oils, polysaccharides
and coumarin derivatives, several pharmacological actions
may be attributed to Danggui, including anticoagulation
and antiplatelet activities, as well as hematopoiesis, immune
support and uterine tonicity (see [12, 13, 21–33], Table 1).
These three essential herbs have been used for thousands of
years in Asia and ﬁrst documented in Shen-nong-ben- cao-
jing, the ﬁrst Chinese medical pharmacopoeia written in the
Han dynasty.
The beneﬁcial eﬀects of these plants on cerebrovascular
disorders have drawn increasing attention in recent research.
Clinically, a great deal of traditional herbal formulae
comprising Fu Ling, Bai Zhu and Danggui (FBD) were
applied to cure ischemia stroke and vascular dementia (VD),
mostly with good eﬃcacy. Statistical analysis showed that
the three herbs are frequently used in formulae, notably
anti-stroke/VD formula Toki-Shakuyaku-San or Yi-Gan San
[34, 35]. To some extent, clinical neuroprotection of the
three herbs was shown to be relevant to their antioxidant
properties [10, 36, 37]. As traditional Chinese nourishing-
tonifying drugs, crude extracts of Fu Ling, Bai Zhu and/or
Danggui have the capacity to inhibit cellular lipid peroxi-
dation (LPO) induced by free radicals, for example, H2O2
[21–23], as well as preserve tissue GSH status and GSH-
Px activity [11, 24]. However, in vitro,t h e i rd i r e c tf r e e
radical scavenging activities are relatively weak due to high
concentration in various biochemical reactions, including
xanthine-xanthine oxidase (XO) system and Fenton reaction
system [12, 13]. Therefore, it is hypothesized that FBD
exerts its protective eﬀects against I/R-induced neuronal
oxidative stress, largely via inhibiting LPO and maintaining
endogenous antioxidant system, instead of scavenging free
radicals.
The primary aim of this study was to evaluate the herbal
formula on neuronal oxidative stress induced by middle
cerebral artery occlusion (MCAO) in vivo and by H2O2 in
vitro. In addition, we evaluated scavenging activities of FBD
against O•−
2 generated in xanthine-XO system and •OH
generated in Fenton reaction system to assess its antioxidant
properties.
2.Methods
2.1. Preparation of Aqueous Extract of FBD. The three herbal
materials used in this work were purchased from Nanjing
herbal materials company (Nanjing, China) and authenti-
cated by Prof. Boyang Yu, Department of Pharmacognosy,
China Pharmaceutical University. Clinically, a single formula
of FBD consisted of 10g P. cocos,5gA. macrocephala and
3gA. sinensis and the aqueous extract of FBD was prepared
the three components were macerated for 30min, decocted
for 30min with 8 times (v/w) double-distilled H2Oa n dt h e
ﬁltrate obtained was concentrated and dried in vacuum at
60◦C into a brown powder, with a yield of 12.5% (w/w).
2.2. Reagents and Chemicals. Vit E, Vit C, 2,3,5-triphenyl-
tertrazolium chloride (TTC), 1,10-phenanthroline and 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) were purchased from Sigma (St Louis, MO). EGb761
was purchased from Schwarz Pharma AG (Monheim, Ger-
many). Medical kits for malondialdehyde (MDA), nitric
oxide(NO),GSHandSODassayswerepurchased fromNan-
jing Jiancheng Bioengineering Institute (Nanjing, China).
2.3. Animals and Pretreatment. Male Sprague-Dawley rats
weighting 250–350g were randomized into four groups:
rats in FBD-pretreated groups received FBD (250mgkg−1,
p.o.), while EGb761-pretreated rats were given EGb761
(24mgkg−1, p.o.), as positive control. Sham-operated
group and vehicle-pretreated group were given p.o. vehicle
0.5% carboxymenthylcellulose-saline. Vehicle or drugs were
administrated once daily for 7 consecutive days. The animal
handling procedures were in compliance with the China
National Institutes of Healthy Guidelines for the Care and
Use of Laboratory Animals.
2.4. Middle Cerebral Artery Occlusion. One hour after the
seventh administration, rats were subject to 1h right MCAO
using the intraluminal ﬁlament technique [38]. Brieﬂy, rats
were anesthetized with chloral hydrate (400mgkg−1, i.p.).
The right common carotid artery was exposed at the level
of the external and internal carotid artery (ECA and ICA)
bifurcation. A 4-0 monoﬁlament nylon suture was inserted
into the ECA and advanced into the ICA for 17–20 mm until
a slight resistance was felt, to block the origin of the middleEvidence-Based Complementary and Alternative Medicine 3
cerebral artery. One hour after MCAO, the suture was slowly
withdrawn. The sham-operated rats did not suﬀer MCAO,
except with exposure to ECA and ICA. Animals were then
returned to their cages for 24h and closely monitored, with
body temperature kept at 37 ± 0.5
◦C.
2.5. Neurological and Histological Examination. The neuro-
logical deﬁcits in rats were assessed after 24h reperfusion.
Ten rats from each group were assigned a numerical score
on a 5-point scale as described: no neurological deﬁcit =
0; failure to fully extend right paw = 1; circling to right
= 2; falling to right = 3; did not walk spontaneously and
had depressed levels of consciousness = 4[ 39]. Then, rats
were killed and brain tissue was removed and sliced into
2.0mm thick coronal sections. Brain slices were incubated
in 2% TTC saline solution at 37◦C for 30min, then ﬁxed in
10%phosphate-buﬀeredformalinfor45min.Infarctvolume
in brain slices, outlined in white, were captured with a
digital camera and measured by image analysis system (Zeiss
AxioVs 40, Oberkochen, Germany) and calculated using the
following equation: % infarct volume = infarct volume/slice
volume × 100%.
2.6. Neurochemical Assays. Twenty-four hours after reperfu-
sion, rats were sacriﬁced and cortical cortexes were collected.
A 10% (w/v) homogenate was prepared in ice-cold saline
and the supernatant was obtained after centrifugation at
3000r.p.m. for 15min. Neurochemical assays were con-
ducted in accordance with the speciﬁcation of medical kits.
When unsaturated fatty acids undergo LPO, MDA is formed.
Thiobarbituric acid reaction was used to determine MDA
(expressed as μmolg−1 protein) [40]. Nitrite in cortical
supernatant was measured after reaction with Griess reagent
(sulfanilamide 1%,naphthylethylene diamine 0.01%,H3PO4
5%) with sodium nitrite as a standard, by which NO
production might be assessed as micromole per gram of
protein [41]. The assay for SOD was based on its ability
to inhibit the oxidation of oxymine by the xanthine-XO
system (expressed as U mg−1 protein) [42]. GSH (expressed
as μmol g−1 protein) was measured through a reaction using
dithiobisnitrobenzoic acid, as described by Ball [43]. Protein
concentration was measured by Lowry method with bovine
serum albumin as standard.
2.7. Sampling of Cerebrospinal Fluid. Fresh cerebrospinal
ﬂuid (CSF) was sampled 0, 0.5, 1, 1.5, 2.0 and 2.5h after
the seventh administration, from FBD-pretreated rats free of
MCAO, using three rats per time point. In short, rats were
anesthetized with chloral hydrate (400mgkg−1, i.p.), 30–
50μl CSF was carefully pricked from bulbus medullae pool
using a sterile injection syringe [44]. After centrifugation at
3000r.p.m. for 10min, the CSF containing FBD (CSF-FBD)
was stored at −20◦C.
2.8.OxidativeInsult inPC12Cells InducedbyH2O2. Neuron-
like pheochromocytoma (PC12) cells were provided by
Institute of Cells Biology (Shanghai, China). The cells were
suspended in Dulbecco Modiﬁed Eagle’s Medium supple-
mented with 10% heat-inactivated newborn calf serum,
benzylpenicillin (100 kU l−1) and streptomycin (100mgl−1)
and incubated at 37
◦Ci n5 %C O 2. PC12 cells were exposed
to H2O2 (200μM) for 1h to induce oxidative insult, then
treated with CSF-FBD (v/v), Vit E (10μM) or blank CSF.
Twenty hours later, MTT assay was performed to observe
the cell viability in PC12 cells [37]. Brieﬂy, MTT solution
(0.5mgml−1) was added to each culture well. After incuba-
tion for 4h, the formazan crystals were dissolved by addition
of 50μl dimethyl sulfoxide and read at dual wavelength,
570nm/650nm.
2.9. Superoxide Radical Generated in Xanthine-Xanthine Oxi-
dase System. Accordingto Link and Riley[45], the xanthine-
XO system of a ﬁnal volume of 2.0ml contained 375μmol
l−1 xanthine,6.25Ul−1 XO,500μmoll−1 hydroxylamine, 100
mmol l−1 Na2HPO4·12H2O–NaH2PO4·2H2Ob u ﬀer (pH
7.8) and FBD or Vit C at diﬀerent concentrations (0.05–
5mgml −1). Reaction was initiated by adding XO and the
tubeswereincubatedat37
◦Cfor40minandthenterminated
by placing in an ice bath. The absorbance of nitrate from
hydroxylamine was measured at 550nm after reaction with
Griess reagent. O•−
2 scavenging by FBD was calculated by the
following equation: %Scavenging rate = [1−A1/A0] × 100%
[A0: Control; A1:D r u g ] .
2.10. Hydroxyl Radical Generated in Fenton Reaction Sys-
tem. The Fenton reaction system of a ﬁnal volume of
2ml contained 0.75mmol l−1 FeSO4, 0.75mmol l−1 1,10-
phenanthroline, 0.8mmoll−1 H2O2, 150mmoll−1 PBS
buﬀer and FBD or Vit C at diﬀerent concentrations (0.05–
5mgml −1). Reaction was initiated by adding H2O2 and
the tubes were incubated for 60min in a water bath at
37
◦C. The absorbance of the Fe2+-phenanthroline complex
was measured at 510 nm [46]. All values represent the
average of triplicate experiments. •OH scavenging by FBD
was calculated by the following equation: %Scavenging rate
=[1−(A2−A1)/(A2−A0)]×100%[A0:Control;A1:Drug;A2:
Blank without drug and H2O2].
2.11. Statistical Analysis. SPSS 12.0 software and Origin 7.0
software were applied to analyze experimental data and
results were expressed as mean ± SD.All data were evaluated
with analysis ofvariance (ANOVA)following by Dunnett’st-
test for multiple comparisons and P < .05 indicates that the
diﬀerence was statistically signiﬁcant.
3.Results
3.1. Neuroprotective Eﬀects of FBD In Vivo. Rats surviving
more than 24 h awakened from anesthesia with a moderately
severe left hemiparesis and circlingmovements. TTC staining
indicated that infarction zone existed in right lobus tempo-
ralis cortical and striatal tissues. The neurological score and
infarct size in the vehicle-pretreated MCAO rats rose up to
2.6 ± 0.7 and 19.7% ± 2.2%, respectively, indicating that I/R4 Evidence-Based Complementary and Alternative Medicine
Table 2: Eﬀects of the aqueous extract of FBD on the contents of MDA, NO and GSH, and SOD activity in rat brain subject to MCAO.
Group Dose (mg/kg) NO (μmol/g prot) MDA (μmol/g prot) GSH (μmol/g prot) SOD (U/mg prot)
Sham 4.58 ± 0.75 3.77 ± 0.83 45.33 ± 5.54 143.07 ± 26.65
MCAO 7.94 ± 0.74## 6.68 ± 0.54## 27.08 ± 3.92## 96.57 ± 22.78##
EGb761 24 6.01 ± 0.96∗∗ 4.56 ± 1.72∗∗ 35.03 ± 6.06∗∗ 124.43 ± 15.77∗∗
FBD 250 6.25 ± 0.80∗∗ 4.64 ± 0.96∗∗ 32.51 ± 5.00∗ 131.73 ± 22.40∗∗
All the data were shown as the mean ± SD, n = 10−12. Signiﬁcance was evaluated with one-way analysis of variance (ANOVA) following by two-sided
Dunnett’s t-test. ##P <. 01 versus the sham-operated group; ∗P <. 05, ∗∗P <. 01 versus the vehicle-pretreated MCAO group.
resulted in neuronal injury. In comparison to the vehicle-
pretreated group, FBD (250mgkg−1) signiﬁcantly reduced
the neurological score by 28.4% (P < .05) and infarct size
by 20.1% (P < .01). Its actions were to some extent stronger
than those of 24mgkg−1 EGb761 (by 27.6%, P < .05 and by
18.9%, P < .01, resp., Figure 1).
3.2.AntioxidantEﬀectsofFBDInVivo. MCAO-inducedneu-
rochemical changes are shown in Table 2. After 24 h reper-
fusion, MDA and NO contents in vehicle-pretreated group
rose signiﬁcantly (P < .01); in contrast, GSH content and
SOD activity reduced signiﬁcantly (P < .01), which implied
that oxidative stress occurred. With respect to the vehicle-
pretreated group, FBD (250mgkg−1) signiﬁcantly reduced
MDA and NO production (P < .01) and restored SOD activ-
ity (P < .01) and GSH content (P < .05); likewise, EGb761
signiﬁcantly suppressed oxidative stress to a similar extent.
3.3. Antioxidant Activity of FBD Ex Vivo. Incubation with
H2O2 for 3h signiﬁcantly reduced cell viability. However,
when the cells were treated with rat CSF-FBD, the observed
cell toxicity was signiﬁcantly attenuated. As illustrated
in Figure 2, CSF-FBD markedly reduced H2O2 injury
within 1.5h in a time-dependent manner (ET50 1.2h) and
concentration-dependant manner within 20% (IC50 10.6%).
Meanwhile, blank CSF had no obvious inﬂuence on the
control PC12 cells and Vit E (10 mM) protected PC12 cells
by only 25.2%.
3.4. Free Radical Scavenging Activity of FBD In Vitro.
Direct free radical scavenging activity by FBD is shown in
Figure 3. At concentrations of 0.05–5.0mgml−1,F B De x h i b -
ited concentration-dependent scavenging activities against
O
•−
2 generated in xanthine-XO system and •OH generated
in a Fenton reaction system, with IC50 2.4mgml−1 and
3.6mgkg−1, respectively, higher than those of Vit C (IC50
0.01mgml−1 and 0.25mgml−1,r e s p . ) .
4.Discussion
This study demonstrates the neuroprotective potential of
FBD against MCAO-induced oxidative stress in rats, as
well as H2O2-induced oxidative stress in neuron-like PC12
cells. Its neuroprotection appears to reduce LPO and restore
endogenous antioxidant system but not scavenge free radi-
cals.
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Figure 1: Eﬀects of aqueous extract of FBD on neurological
score and brain infarction in rats subject to MCAO. Each column
represents the mean ± SD of 10–12 rats. Signiﬁcance was evaluated
with one-way ANOVA following by two-sided Dunnett’s t-test.
∗P <. 05,
∗∗P <. 01 versus the vehicle-pretreated MCAO group.
It is well documented that transient focal MCAO results
in neurological and histological abnormality. Our results
indicated that pretreatment with FBD oﬀered protection
against cortical and striatal neuronal damage induced by
MCAO, as FBD reduced the neurological score and infarct
size (Figure 1), in harmony with other studies [47, 48].
Free radical involvement in the development of I/R-
induced brain injury is well investigated [3, 4], among
which, O
•−
2 and •OH are potent by inducing LPO [49]. The
highly reactive •OH is formed from H2O2 in the presence
of divalent metal ions, especially Fe2+ and Cu2+,v i at h e
Fenton reaction. In addition, during ischemia, xanthine
dehydrogenase undergoes irreversible proteolytic conversion
to XO, producing O
•−
2 and H2O2 i nt h ep r e s e n c eo fo x y g e n
[3]. O•−
2 does not directly induce LPO but can react with
•NO to form cytotoxic peroxynitrite (ONOO−)[ 50]. We
found that focal MCAO induced increases of LPO and NO
(Table 2), in agreement with recent studies [51, 52]. FBD
inhibited NO production but its scavenging activity against
either •OH or O
•−
2 was feeble compared to that of Vit C
(Figure 3), supporting previous ﬁndings that P. cocos and A.
sinensis were relatively weak natural free radical scavengers
[13].
The overproduction of free radicals can be detoxiﬁed
by endogenous antioxidants, causing their cellular stores
to be depleted [52, 53]. Physiologically, SOD reacts with
O
•−
2 to form H2O2; Catalase and GSH-Px are involved
in the detoxiﬁcation of H2O2; GSH, which is consideredEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀect of rat CSF-FBD on PC12 cells induced by hydrogen peroxide. All the data were shown as the mean ± SD, n = 6. Signiﬁcance
was evaluated with one-way ANOVA following by two-sided Dunnett’s t-test.
∗P <. 05,
∗∗P <. 1,
∗∗∗P <. 001 versus blank CSF.
the most prevalent and important intracellular non-protein
thiol, has a crucial role as a free radical scavenger. Here,
GSH content and SOD activity were signiﬁcantly reduced
(Table 2). Similar to EGb761, FBD signiﬁcantly prevented
SOD activity and GSH content decline caused by MCAO.
In addition to restoring the endogenous antioxidant
system, anti-LPO activity was also implicated in the antiox-
idant properties of FBD. In 1996, Taylor et al. observed
the inhibition of T cells by human CSF, and in 2000,
Nakagawa et al. found human CSF altered intracellular
calcium regulation in endothelial cells [54, 55]. Since CSF is
the natural vehicle for CNS agents, both reports enlightened
us to design a novel experimental method to evaluate
neuroeﬀectiveness of FBD ex vivo. PC12 cells injured by
H2O2 are a typical model used to evaluate anti-LPO activity
of drug on neuronal oxidative stress [56, 57]. In this work,
CSF-FBD attenuated oxidative insult aﬀects PC12 cells in
bothtime-andconcentration-dependentmanner (Figure 2),
in accordance with in vivo ﬁnding that MDA levelin MCAO-
subjected rats was depressed by FBD extract.
The exact mechanism by which FBD abated oxidative
stress is not yet clear but it is strongly believed that recently
identiﬁed active compounds may be responsible. Triterpenes
from Fu Ling inhibited FeCl2-ascorbicacid inducedLPO and
lysis of red blood cells [14]. Atractylon from Bai Zhu inhib-
ited LPO by CCl4 in liver lesion and its acetylene compound
(6E,12E)-tetradecadiene-8,10-diyne-1,3-diol diacetate sup-
pressed gastric lesions induced by I/R, via inhibition of
XO [17, 18]. Z-ligustilide from Danggui protected against
H2O2-induced cytotoxicity in PC12 cells and forebrain
I/R by enhancing antioxidant defense [25, 26]. Coniferyl
ferulate is the main antioxidant from essential oil of Danggui
[27] and ferulic acid could reduce neuronal damage from
exposure to iron, hydroxyl and peroxyl radicals [28, 29].
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Figure 3: Scavenging activities of aqueous extract of FBD against
superoxide anion radical generated in xanthine-XO system and
hydroxyl radical generated in Fe2+/H2O2 Fenton reaction system
with ascorbic acid as a positive control. Values were means ± SD,
n = 6.
Inaddition,Danggui polysaccharidesprotectedmacrophages
against tert-butylhydroperoxide-induced oxidative injury
[30, 31].
In conclusion, our present ﬁndings suggested that FBD
might exert protection against neuronal oxidative stress,
induced by either MCAO in vivo or H2O2 in vitro.I ti s
a distinct botanical antioxidant agent to reduce LPO and
restore the endogenous antioxidant system, without the
activity of free radical scavengers. This research expands6 Evidence-Based Complementary and Alternative Medicine
and elaborates the biological model underlying one com-
plementary and alternative medicine treatment for neuronal
oxidative stress.
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